Skip to main
CLPT

CLPT Stock Forecast & Price Target

CLPT Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ClearPoint Neuro Inc. is positioned for a positive growth trajectory, demonstrating 17% topline growth in 2023 along with a significant reduction in cash burn, indicating improved profitability. The company's anticipation of over 20% revenue growth in 2024, supported by the expansion of its partnership base and higher value service offerings, reinforces its sustainable growth potential. Furthermore, momentum is bolstered by recent product approvals, record system installations, and supportive clinical publications, reducing regulatory risk and enhancing the overall outlook for the business.

Bears say

ClearPoint Neuro has demonstrated a significant reduction in cash burn, decreasing from $5.8 million in the first quarter of 2023 to $1.2 million by the fourth quarter, which signals improved cash management. Despite this positive trend, the ongoing reliance on cash conservation measures raises concerns regarding the company's operational sustainability and growth prospects. Furthermore, the financial metrics indicate potential underlying challenges in revenue generation or market demand, contributing to a negative outlook on the stock.

CLPT has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Clearpoint Neuro Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Clearpoint Neuro Inc (CLPT) Forecast

Analysts have given CLPT a Strong Buy based on their latest research and market trends.

According to 2 analysts, CLPT has a Strong Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Clearpoint Neuro Inc (CLPT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.